These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 9384259
1. DY-9760e, a novel calmodulin antagonist with cytoprotective action. Sugimura M, Sato T, Nakayama W, Morishima Y, Fukunaga K, Omitsu M, Miyamoto E, Shirasaki Y. Eur J Pharmacol; 1997 Oct 01; 336(1):99-106. PubMed ID: 9384259 [Abstract] [Full Text] [Related]
3. The post-ischemic administration of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, prevents delayed neuronal death in gerbil hippocampus. Hashiguchi A, Yano S, Morioka M, Hamada J, Shirasaki Y, Kochi M, Fukunaga K. J Pharmacol Sci; 2004 Sep 01; 96(1):65-72. PubMed ID: 15359085 [Abstract] [Full Text] [Related]
4. 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, reduces brain edema through the inhibition of enhanced blood-brain barrier permeability after transient focal ischemia. Sato T, Morishima Y, Shirasaki Y. J Pharmacol Exp Ther; 2003 Mar 01; 304(3):1042-7. PubMed ID: 12604680 [Abstract] [Full Text] [Related]
5. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K. Drug Metab Dispos; 2005 Nov 01; 33(11):1628-36. PubMed ID: 16049129 [Abstract] [Full Text] [Related]
7. Cytoprotective effect of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) against ischemia/reperfusion-induced injury in rat heart involves inhibition of fodrin breakdown and protein tyrosine nitration. Hashimoto M, Takada Y, Takeuchi Y, Kasahara J, Hisa H, Shirasaki Y, Fukunaga K. J Pharmacol Sci; 2005 Jun 01; 98(2):142-50. PubMed ID: 15937403 [Abstract] [Full Text] [Related]
11. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart. Fukunaga K, Han F, Shioda N, Moriguchi S, Kasahara J, Shirasaki Y. Cardiovasc Drug Rev; 2006 Jun 01; 24(2):88-100. PubMed ID: 16961723 [Abstract] [Full Text] [Related]
14. DY-9760e, a calmodulin antagonist, reduces brain damage after permanent focal cerebral ischemia in cats. Sugimura M, Takamori H, Fukushi H, Kitano Y, Kanazawa Y, Shirasaki Y. Biol Pharm Bull; 2005 Apr 01; 28(4):629-33. PubMed ID: 15802800 [Abstract] [Full Text] [Related]
15. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys. Tachibana S, Fujimaki Y, Tachibana M, Tanaka M, Kurata T, Okazaki O, Sudo K. Arzneimittelforschung; 2005 Apr 01; 55(3):135-44. PubMed ID: 15819385 [Abstract] [Full Text] [Related]
16. Determination of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, DY-9760e, in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. Tachibana S, Fukano A, Sudo K, Tanaka M. J Chromatogr B Biomed Sci Appl; 1999 Oct 29; 734(1):39-45. PubMed ID: 10574188 [Abstract] [Full Text] [Related]
17. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities. Lu YM, Shioda N, Han F, Kamata A, Shirasaki Y, Qin ZH, Fukunaga K. Cardiovasc Ther; 2009 Oct 29; 27(1):17-27. PubMed ID: 19207476 [Abstract] [Full Text] [Related]